Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital development | An XX baby may have atypical external genitalia after maternal androgen exposure; severity can vary. | Genital atypicality is not established as a defining feature in the supplied description. | High |
| Growth and development | The core issue is prenatal androgen effect rather than a described multisystem deletion syndrome. | Developmental delay, growth concerns, and multiple congenital differences are described. | High |
| Underlying category | Endocrine exposure during pregnancy; it is not communicable. | Genetic copy-number change involving chromosome 3q26q28. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and a documented maternal androgen source
This pattern matches the supplied endocrine mechanism better than a deletion syndrome.
Moderate
Findings are mainly reproductive or genital rather than broad congenital anomalies
The supplied left condition centers on sex development from androgen exposure.
Moderate
Counseling concerns hormones or possible genital surgery
Specialist endocrine and surgical guidance is specifically described for the left condition.
Moderate
Choose 3q26q28 Deletion Syndrome C6010434 when
Developmental delay, growth issues, and multiple congenital differences
These features are described for 3q26q28 deletion syndrome.
Moderate
Genetic testing identifies a 3q26q28 deletion
A confirmed deletion supports the genetic diagnosis over androgen exposure alone.
High
No maternal androgen source explains the presentation
Absence of that exposure makes the left condition less likely, but does not prove the deletion.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | No 3q26q28 deletion is expected from the supplied description. | May detect a deletion involving 3q26q28; confirmation is required. | A deletion supports the right condition but must be interpreted by a genetics clinician. |
| Karyotype | The named condition applies to a 46,XX chromosomal sex pattern. | A standard karyotype may miss a small deletion. | Karyotype alone cannot reliably separate these conditions. |
| Endocrine and exposure review | History of maternal-derived androgen exposure is central; no cutoff is supplied. | Not explained by maternal androgen exposure alone. | Abnormal hormone results are not themselves a diagnosis and need clinical correlation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Chronic course with variable genital and hormonal effects; quantitative prognosis is not established.
- Factors
- Extent of androgen effect, anatomy, and access to specialist care.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Chronic course varying with developmental, growth, and congenital findings.
- Factors
- Deletion characteristics and associated clinical findings, which are not fully specified here.
Time frame: Often recognized prenatally or in early life, with long-term follow-up; exact timing varies.
Accurate diagnosis, supportive care, and monitoring of individual complications.
Complications comparison
| Complication | Presentation |
|---|---|
| Associated medical complexity | May involve atypical genital anatomy and decisions about hormone or surgical care. May involve congenital differences, growth concerns, and developmental needs. Specific complications and their frequency are not established here. |
| Psychosocial impact | Sex-development findings may require sensitive, ongoing support. Developmental and congenital findings may affect learning and caregiving needs. Impact varies; no comparative rate is supplied. |
| Long-term specialist needs | Endocrine and reproductive follow-up may be relevant. Genetics, development, and organ-specific follow-up may be relevant. Care should be individualized rather than protocolized from these data. |
Patient education highlights
- HighDifferent causes
One condition involves prenatal androgen exposure in an XX baby; the other involves a chromosome 3 deletion.
- HighTesting limits
A test abnormality is not automatically a diagnosis. Results need specialist interpretation.
- MediumVariable course
Supplied severity labels differ, but individual outcomes and exact risks are not established here.